PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FAE9B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $214,336
Award facts
- Contract value 100% obligated
- $214,335.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $214,335.89 by the Defense Logistics Agency's Medical Supply Chain, with performance completion scheduled for January 2, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.
This delivery order supports the Defense Logistics Agency's mission to supply critical pharmaceutical commodities to military and veteran healthcare systems. AmerisourceBergen's contract portfolio with the DLA demonstrates the company's capability to fulfill federal procurement requirements through open competition across diverse medical supply categories. The parent IDC is part of the DLA Troop Support's broader pharmaceutical procurement strategy and enables the company to serve multiple government healthcare customers, including the Defense Health Agency and U.S. Coast Guard, providing flexible and comprehensive pharmaceutical support capabilities to sustain military medical readiness worldwide.
Quick answers
Who was awarded contract SPE2D826FAE9B?
SPE2D826FAE9B was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 1, 2026.
How much is contract SPE2D826FAE9B worth?
The government has obligated $214,336 on SPE2D826FAE9B.
Is contract SPE2D826FAE9B an order under another contract?
Yes. SPE2D826FAE9B is a delivery order under SPE2DX22D0099, an indefinite delivery contract.
Was contract SPE2D826FAE9B competed?
The extent of competition for SPE2D826FAE9B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award